The Department of Justice (DOJ) has announced it’s withdrawing dozens of proposed rules—including one to implement a law expanding marijuana research and another on hemp analytic testing that curiousl...

#MarijuanaReform #trumppolicy Trump moves to ease US marijuana regulations, sparking industry hopes President Trump has signed an order recommending the reclassification of marijuana, potentially moving it from Schedule I to Schedule III. This change could unlock billions for research, ease restrictions, and open doors for the cannabis industry, while medical use becomes easier for patients. Marijuana remains federally illegal, but the move marks a historic shift in U.S.

On today's Podcast show, we talk about the end of an era for AOL Dialed up Internet service that got the whole country online. Then we talk about why marijuana should not be a federal issue and should...

The Trump administration’s move to reschedule marijuana is popular, but most people support even broader cannabis reforms, according to a new federally funded study that examines public comments recei...

Green Thumb Industries CEO Ben Kovler shares a bleak outlook on federal marijuana reform, criticizing government agencies and highlighting the company’s strong financial performance despite regulatory...

YouTube video by B.C. Begley

President Trump says he'll decide on marijuana rescheduling in the next few weeks. This follows con...

Alexandria Police Officer Brian Willett was charged today with several crimes for doing something th... #brianwillett #marijuana #drugs #racism #blacklivesmatter

(Reuters) -U.S. President Donald Trump’s administration is looking to reclassify marijuana as a less dangerous drug, a shift that could ease criminal penalties and reshape the pot industry by lowering tax burdens and making it easier for firms to secure funding. Trump said on Monday a decision could come within the next couple of weeks. U.S.-listed cannabis-linked stocks rose in pre-market trading on Tuesday, led by a 13% jump in Canopy Growth (NASDAQ:CGC). Organigram Global, SNDL, Aurora Cannabis (NASDAQ:ACB) and Tilray (NASDAQ:TLRY) Brands gained between 3% and 12%. WHAT DOES RECLASSIFYING ENTAIL? Under the Controlled Substances Act, marijuana is listed as a Schedule I substance, meaning it has a high potential for abuse and no current accepted medical use. Reclassifying marijuana as a less dangerous drug could unlock banking access for pot producers, attract institutional investors, reduce tax burden and spur mergers and acquisitions. Securing funding remains one of the biggest challenges for cannabis producers, as federal restrictions keep most banks and institutional investors out of the sector, forcing pot producers to turn to costly loans or alternative lenders. Last year, the Biden administration asked the Department of Health and Human Services to review marijuana’s classification, and the agency recommended moving it to Schedule III, a category for substances with a moderate to low risk of physical or psychological dependence. WHAT WOULD BE THE TAX IMPLICATIONS? One of the biggest benefits from a reclassification would be that cannabis firms would no longer be subject to Section 280E of the U.S. federal tax code. That provision prevents businesses dealing in Schedule I and II controlled substances from claiming tax credits and deductions for business expenses. WHAT COMES NEXT? TD Cowen analyst Jaret Seiberg said full legalization remains unlikely, citing a lack of meaningful support in Congress and limits on how far the Drug Enforcement Administration (DEA) can go through rescheduling alone. "It seems more likely to us that Trump would revive the effort at the DEA to move cannabis to Schedule III, which would permit the government to regulate it," said Seiberg. Cannabis will remain federally illegal, interstate trade will not be allowed and the silo system of each state deciding their own market rules will still apply, according to equity research firm Zuanic & Associates. Before you buy stock in WEED, consider this: ProPicks AI are 6 easy-to-follow model portfolios created by Investing.com for building wealth by identifying winning stocks and letting them run. Over 150,000 paying members trust ProPicks to find new stocks to buy – driven by AI. The ProPicks AI algorithm has just identified the best stocks for investors to buy now. The stocks that made the cut could produce enormous returns in the coming years. Is WEED one of them?

‘Reform archaic dagga laws’ …as push for legalisation continues  New Era Namibia

Cannabis convictions have ruined millions of lives. Add your name and tell your representatives to support legislation to change that.

The move should make it easier for researchers to study the substance and give tax breaks to licensed medical marijuana dealers